Tumor-associated regulatory factors exert regulatory effects on downstream HER2 signaling, with possible mechanisms involving competitive inhibition, prevention of degradation of key downstream proteins, and inhibition of ubiquitin-mediated degradation. The gene discussed is ERBB2; the disease is neoplasm.